- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
SynAging
SynAging is listed as a small business research supplier in the Scientist.com network, with 2 sites in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Disease Models
- Excitotoxicity Models Measure therapeutic endpoints in animal models with excitotoxic pathology.
In Vitro Pharmacology
- In Vitro Excitotoxicity Models Use in vitro models to measure therapeutic endpoints associated with excitotoxic pathology.
Where it operates
Sites by country, with the cities in each.
-
France 2 sites
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
SynAging is a contract research organization (CRO), providing new insights and disease-related understanding of drug candidates (small molecules and biopharmaceuticals), nutraceuticals and other active substances by deploying neurodegenerative disease models. SynAging provides: In vitro services Investigating single to hundreds of compounds in primary neuronal tissue culture and neuronal cell lines. In vivo services Investigating drug-induced changes in established behavioral paradigms using proprietary disease models. SynAging maintains and is open to new long-term strategic research...
Show the full description
SynAging is a contract research organization (CRO),
providing new insights and disease-related understanding of drug candidates (small molecules and biopharmaceuticals), nutraceuticals and other active substances by deploying neurodegenerative disease models.
SynAging provides:
In vitro services
Investigating single to hundreds of compounds in primary neuronal tissue culture and neuronal cell lines.
In vivo services
Investigating drug-induced changes in established behavioral paradigms using proprietary disease models.
SynAging maintains and is open to new long-term strategic research collaborations for studying proteopathic neurodegenerative diseases.
SynAging’s service team has more than 90 years of combined experience in the field of neurodegenerative disease research. Key staff has published more than 35 peer-reviewed publications.
In addition, SynAging provides ex vivo services, investigating brain tissues from disease models for biochemical changes, which are treatment related, e.g. gene expression changes, protein amount changes, protein phosphorylation changes, functional changes.
- Website
- www.synaging.com
Work with SynAging on Scientist.com
For prices, more details, or to contact SynAging, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.